- Home
- MYNZ vs IBG Comparison
MYNZ vs IBG Comparison
Compare MYNZ & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MYNZ | IBG |
|---|---|---|
| Founded | 2021 | 2018 |
| Country | Germany | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8M | 8.8M |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | MYNZ | IBG |
|---|---|---|
| Price | $1.23 | $2.43 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | 197.9K | ★ 244.3K |
| Earning Date | 12-29-2025 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $659,935.00 | ★ $2,931,243.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.03 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.92 | $1.48 |
| 52 Week High | $8.20 | $9.85 |
Technical Indicators
Market Signals| Indicator | MYNZ | IBG |
|---|---|---|
| Relative Strength Index (RSI) | 53.56 | 51.03 |
| Support Level | $1.00 | $2.15 |
| Resistance Level | $1.15 | $2.75 |
| Average True Range (ATR) | 0.08 | 0.27 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 87.76 | 35.92 |
Price Performance
Historical ComparisonAbout MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.